Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency
- PMID: 30440043
- PMCID: PMC6237391
- DOI: 10.1371/journal.ppat.1007357
Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency
Abstract
Latently-infected CD4+ T cells are widely considered to be the major barrier to a cure for HIV. Much of our understanding of HIV latency comes from latency models and blood cells, but most HIV-infected cells reside in lymphoid tissues such as the gut. We hypothesized that tissue-specific environments may impact the mechanisms that govern HIV expression. To assess the degree to which different mechanisms inhibit HIV transcription in the gut and blood, we quantified HIV transcripts suggestive of transcriptional interference (U3-U5; "Read-through"), initiation (TAR), 5' elongation (R-U5-pre-Gag; "Long LTR"), distal transcription (Nef), completion (U3-polyA; "PolyA"), and multiple splicing (Tat-Rev) in matched peripheral blood mononuclear cells (PBMCs) and rectal biopsies, and matched FACS-sorted CD4+ T cells from blood and rectum, from two cohorts of ART-suppressed individuals. Like the PBMCs, rectal biopsies showed low levels of read-through transcripts (median = 23 copies/106 cells) and a gradient of total (679)>elongated(75)>Nef(16)>polyadenylated (11)>multiply-spliced HIV RNAs(<1) [p<0.05 for all], demonstrating blocks to HIV transcriptional elongation, completion, and splicing. Rectal CD4+ T cells showed a similar gradient of total>polyadenylated>multiply-spliced transcripts, but the ratio of total to elongated transcripts was 6-fold lower than in blood CD4+ T cells (P = 0.016), suggesting less of a block to HIV transcriptional elongation in rectal CD4+ T cells. Levels of total transcripts per provirus were significantly lower in rectal biopsies compared to PBMCs (median 3.5 vs. 15.4; P = 0.008) and in sorted CD4+ T cells from rectum compared to blood (median 2.7 vs. 31.8; P = 0.016). The lower levels of HIV transcriptional initiation and of most HIV transcripts per provirus in the rectum suggest that this site may be enriched for latently-infected cells, cells in which latency is maintained by different mechanisms, or cells in a "deeper" state of latency. These are important considerations for designing therapies that aim to disrupt HIV latency in all tissue compartments.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.Retrovirology. 2019 Nov 11;16(1):32. doi: 10.1186/s12977-019-0494-x. Retrovirology. 2019. PMID: 31711503 Free PMC article.
-
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents.AIDS. 2020 Nov 15;34(14):2013-2024. doi: 10.1097/QAD.0000000000002684. AIDS. 2020. PMID: 32910065 Free PMC article.
-
Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.J Virol. 2020 Dec 22;95(2):e01331-20. doi: 10.1128/JVI.01331-20. Print 2020 Dec 22. J Virol. 2020. PMID: 33115867 Free PMC article.
-
Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.Viruses. 2020 Aug 8;12(8):868. doi: 10.3390/v12080868. Viruses. 2020. PMID: 32784426 Free PMC article. Review.
-
The multifactorial nature of HIV-1 latency.Trends Mol Med. 2004 Nov;10(11):525-31. doi: 10.1016/j.molmed.2004.09.006. Trends Mol Med. 2004. PMID: 15519278 Review.
Cited by
-
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.Retrovirology. 2019 Nov 11;16(1):32. doi: 10.1186/s12977-019-0494-x. Retrovirology. 2019. PMID: 31711503 Free PMC article.
-
HIV persists throughout deep tissues with repopulation from multiple anatomical sources.J Clin Invest. 2020 Apr 1;130(4):1699-1712. doi: 10.1172/JCI134815. J Clin Invest. 2020. PMID: 31910162 Free PMC article.
-
The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like.Front Immunol. 2019 Sep 20;10:2251. doi: 10.3389/fimmu.2019.02251. eCollection 2019. Front Immunol. 2019. PMID: 31616425 Free PMC article. Review.
-
HIV-1-Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities.Int J Mol Sci. 2023 Jul 30;24(15):12193. doi: 10.3390/ijms241512193. Int J Mol Sci. 2023. PMID: 37569570 Free PMC article. Review.
-
A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency.Open Forum Infect Dis. 2020 Mar 4;7(4):ofaa082. doi: 10.1093/ofid/ofaa082. eCollection 2020 Apr. Open Forum Infect Dis. 2020. PMID: 32284948 Free PMC article.
References
-
- Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387(6629):183–8. 10.1038/387183a0 . - DOI - PubMed
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295–300. . - PubMed
-
- Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278(5341):1291–5. . - PubMed
-
- Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893–900. 10.1038/nm.1972 ; PubMed Central PMCID: PMCPMC2859814. - DOI - PMC - PubMed
-
- Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine. 1999;5(5):512–7. Epub 1999/05/06. 10.1038/8394 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials